NASDAQ:EVOK   Evoke Pharma, Inc.
Price above SMA13
OBV>OBV34
WR > -80

Entry 1.4
Stop 1
Target 3.7

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
Trade active:
BuyToOpen (BTO) 2022 C2.5 0.3x10
Prepare to sell C5
No Stop
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.